For example, animal studies indicated that DCHP may trigger intestinal pregnane X receptor (PXR) activation, potentially elevating cardiovascular disease risk through hypercholesterolemia and ceramide production [15]. This evidence concerns the gene NR1I2 and familial hypercholesterolemia.